The optimization of quantitative reverse transcription PCR for verification of cDNA microarray data

被引:37
作者
Hembruff, SL
Villeneuve, DJ
Parissenti, AA [1 ]
机构
[1] NE Ontario Reg Canc Ctr, Tumor Biol Res Program, Sudbury, ON P3E 5J1, Canada
[2] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada
关键词
Microarray analysis; optimization; Q-PCR; real-time PCR; verification;
D O I
10.1016/j.ab.2005.07.014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
cDNA microarray analysis is highly useful for monitoring genome-wide changes in gene expression that occur in biological processes. Current standards require that microarray observations be verified by quantitative (Q)-PCR or other techniques. Few studies have optimized Q-PCR for verification of microarray findings. The current study assessed several variables affecting Q-PCR fidelity, including RNA extraction methods, mRNA enrichment, primers for reverse transcription, and cDNA amplification detection methods. Also assessed was the choice of reference gene on which other gene expression changes are based. The RNA for ribosomal protein S28 was found to be ideal for this purpose, with minimal variance in expression among isogenic drug-resistant cell lines. We also found that oligo (dT) primers were superior to random hexamers and that RNA extracted by the RNeasy method gave consistent S28 gene amplification without the need for mRNA enrichment, particularly when TaqMan probes were used. Nevertheless, sensitivity was sufficiently high with SYBR Green I that it was the preferred, least costly method for amplification product detection, even for low-abundance transcripts. Using the optimal method, 91-95% of the differences in gene expression identified between the cell lines by cDNA microarray analysis could be confirmed by Q-PCR, significantly superior to previously described methods. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:237 / 249
页数:13
相关论文
共 22 条
[1]   Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR [J].
Aerts, JL ;
Gonzales, MI ;
Topalian, SL .
BIOTECHNIQUES, 2004, 36 (01) :84-+
[2]   A reverse transcription comparative real-time PCR method for quantitative detection of angiogenic growth factors in head and neck cancer patients [J].
Chang, JT ;
Chen, IH ;
Liao, CT ;
Wang, HM ;
Hsu, YM ;
Hung, KF ;
Lin, CJ ;
Hsieh, LL ;
Cheng, AJ .
CLINICAL BIOCHEMISTRY, 2002, 35 (08) :591-596
[3]   A novel method for real time quantitative RT PCR [J].
Gibson, UEM ;
Heid, CA ;
Williams, PM .
GENOME RESEARCH, 1996, 6 (10) :995-1001
[4]   Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream [J].
Ginzinger, DG .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) :503-512
[5]   Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure [J].
Guo, BQ ;
Villeneuve, DJ ;
Hembruff, SL ;
Kirwan, AF ;
Blais, DE ;
Bonin, M ;
Parissenti, AM .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 85 (01) :31-51
[6]  
Huang KC, 2000, J FORMOS MED ASSOC, V99, P839
[7]   Normalization of reverse transcription quantitative-PCR with housekeeping genes in rice [J].
Kim, BR ;
Nam, HY ;
Kim, SU ;
Kim, SI ;
Chang, YJ .
BIOTECHNOLOGY LETTERS, 2003, 25 (21) :1869-1872
[8]   Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria [J].
Maeda, H ;
Fujimoto, C ;
Haruki, Y ;
Maeda, T ;
Kokeguchi, S ;
Petelin, M ;
Arai, H ;
Tanimoto, I ;
Nishimura, F ;
Takashiba, S .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2003, 39 (01) :81-86
[9]   Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice [J].
Maxwell, KN ;
Soccio, RE ;
Duncan, EM ;
Schayek, E ;
Breslow, JL .
JOURNAL OF LIPID RESEARCH, 2003, 44 (11) :2109-2119
[10]  
Morrison TB, 1998, BIOTECHNIQUES, V24, P954